{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:44:42Z","timestamp":1791294282598,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.steroids.2011.12.007","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T05:58:41Z","timestamp":1323410321000},"page":"332-337","source":"Crossref","is-referenced-by-count":145,"title":["Neuroendocrine dysfunction in polycystic ovary syndrome"],"prefix":"10.1016","volume":"77","author":[{"given":"Christine M.","family":"Burt Solorzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer P.","family":"Beller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Abshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessicah S.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.12.007_b0005","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2011.12.007_b0010","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.steroids.2011.12.007_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/beem.2002.0203","article-title":"Adult polycystic ovary syndrome begins in childhood","volume":"16","author":"Franks","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2006.04.028","article-title":"Puberty and polycystic ovary syndrome","volume":"254\u2013255","author":"Witchel","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2011.12.007_b0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.steroids.2011.12.007_b0035","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1016\/j.steroids.2011.12.007_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.12.007_b0045","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1148\/radiology.166.2.3275976","article-title":"Gynecologic imaging: comparison of transabdominal and transvaginal sonography","volume":"166","author":"Mendelson","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.steroids.2011.12.007_b0055","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1210\/jc.2006-0835","article-title":"Functional significance of polycystic-size ovaries in healthy adolescents","volume":"91","author":"Mortensen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/endo-109-2-376","article-title":"Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey","volume":"109","author":"Wildt","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.12.007_b0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0002-9378(71)90872-6","article-title":"Regulation of the human menstrual cycle","volume":"109","author":"Speroff","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2011.12.007_b0070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1210\/mend-3-8-1295","article-title":"Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: an in situ hybridization study","volume":"3","author":"Romano","year":"1989","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.12.007_b0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0080","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1210\/jc.82.12.4179","article-title":"Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation","volume":"82","author":"Daniels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1210\/jc.83.2.582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0090","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/en.2005-1029","article-title":"Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback","volume":"147","author":"Pielecka","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.12.007_b0095","first-page":"155","article-title":"Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles","volume":"47","author":"Marshall","year":"1991","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.steroids.2011.12.007_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0105","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/jc.85.11.4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jc.79.1.119","article-title":"Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome","volume":"79","author":"Apter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/jc.2008-1252","article-title":"Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls","volume":"94","author":"McCartney","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0125","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1210\/jc.2008-2606","article-title":"Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls \u2013 implications for regulation of pubertal maturation","volume":"94","author":"Blank","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0130","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jc.85.3.1074","article-title":"Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children","volume":"85","author":"Mitamura","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0135","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/jc.76.6.1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0140","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/jc.84.8.2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence","volume":"84","author":"Ibanez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.20.4.535","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2011.12.007_b0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2011.12.007_b0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00003081-200306000-00011","article-title":"Insulin sensitizers for polycystic ovary syndrome","volume":"46","author":"Baillargeon","year":"2003","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.steroids.2011.12.007_b0160","unstructured":"Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003; CD003053."},{"key":"10.1016\/j.steroids.2011.12.007_b0165","doi-asserted-by":"crossref","unstructured":"Knudsen KL, Blank SK, Burt Solorzano C, Patrie JT, Chang RJ, Caprio S, et al. Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants. Obesity (Silver Spring) 18:2118\u201324.","DOI":"10.1038\/oby.2010.58"},{"key":"10.1016\/j.steroids.2011.12.007_b0170","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1210\/jc.2009-0959","article-title":"Polycystic ovary syndrome: a model of combinatorial endocrinology?","volume":"94","author":"Berga","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0175","unstructured":"Ogden CL, Lamb MM, Carroll MD, Flegal KM. Obesity and socioeconomic status in children and adolescents: United States, 2005\u20138. NCHS Data Brief:1\u20138."},{"key":"10.1016\/j.steroids.2011.12.007_b0180","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2011.12.007_b0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.steroids.2011.12.007_b0190","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ajp.20679","article-title":"Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys","volume":"71","author":"Abbott","year":"2009","journal-title":"Am J Primatol"},{"key":"10.1016\/j.steroids.2011.12.007_b0200","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1210\/en.140.12.5797","article-title":"In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone","volume":"140","author":"Robinson","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.12.007_b0205","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1095\/biolreprod.105.039800","article-title":"Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator","volume":"72","author":"Foecking","year":"2005","journal-title":"Biol Reprod"},{"key":"10.1016\/j.steroids.2011.12.007_b0210","doi-asserted-by":"crossref","unstructured":"Roland AV, Moenter SM. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology 152:618\u201328.","DOI":"10.1210\/en.2010-0823"},{"key":"10.1016\/j.steroids.2011.12.007_b0215","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2009-0544","article-title":"The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study","volume":"94","author":"Hickey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0220","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2011.12.007_b0225","doi-asserted-by":"crossref","unstructured":"Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo JE, David AL, et al. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol 30:444\u20136.","DOI":"10.3109\/01443615.2010.485254"},{"key":"10.1016\/j.steroids.2011.12.007_b0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.12.007_b0235","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1210\/jc.2009-0427","article-title":"Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Maliqueo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0240","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0245","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/jc.79.5.1328","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.12.007_b0250","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.steroids.2011.12.007_b0255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty","volume":"25","author":"Blank","year":"2007","journal-title":"Semin Reprod Med"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11003527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11003527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T17:13:37Z","timestamp":1561050817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11003527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0039128X11003527"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.12.007","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}